Lancet Microbe

The Lancet Microbe is a prestigious gold open-access journal published by Elsevier, part of The Lancet family, dedicated to advancing the understanding of microbial pathogenesis, epidemiology, and clinical management. With an exceptional 2026 Impact Factor of 86.2080 and a JCR Quartile ranking of Q1, it stands among the most influential and highly cited publications in microbiology and infectious diseases. The journal’s scope encompasses a broad spectrum of topics, including bacterial, viral, fungal, and parasitic infections, antimicrobial resistance, microbiome research, vaccine development, and emerging zoonotic threats. It prioritizes studies that bridge laboratory science with clinical and public health practice, emphasizing translational research that informs diagnosis, treatment, and prevention strategies. The Lancet Microbe publishes original research articles, comprehensive reviews, commentaries, and correspondence, with a strong preference for high-quality, methodologically rigorous studies that offer significant insights into microbial biology and infectious disease dynamics. Its target audience includes academic researchers, clinicians, infectious disease specialists, epidemiologists, public health policymakers, and microbiologists seeking cutting-edge evidence and authoritative perspectives. Notable features include rigorous peer review, rapid publication times for priority findings, and a commitment to open-access dissemination, ensuring global accessibility. The journal’s standing in the field is extraordinary, consistently ranking at the very top of microbiology and infectious disease journals, making it a premier destination for landmark studies that shape clinical guidelines and scientific paradigms.